Biotech News

EyePoint Announces Participation at Upcoming Investor Conferences and Scientific Meetings

EyePoint Pharmaceuticals (EYPT)EyePoint PharmaceuticalsCompany update

EyePoint, Inc. (Nasdaq: EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives of patients with serious retinal diseases, today announced that the Company will participate at the following upcoming conferences:

Related news

EyePoint Pharmaceuticals

Retinal Disease Focus EyePoint Pharmaceuticals develops sustained-delivery therapies for serious retinal diseases. Its programs are designed to reduce the treatment burden associated with frequent intravitreal injections while maintaining durable control of retinal vascular disease. DURAVYU Technology DURAVYU combines vorolanib, a...

Recent company news

Stock data

Close
0.26 USD
Market cap
1.05B USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States